Focus:
Research Reports
-
8 January 2020
Multiple sclerosis market to reach $32.9bn in 2028 driven by launch of pipeline agents, says GlobalData
Multiple Sclerosis is an autoimmune disorder that involves recurring inflammatory attacks on the central nervous system. This is caused by a dysfunctional immune system and leads to neurological disability. Multiple...
-
8 January 2020
Pharma industry is prioritizing big data, blockchain, cloud computing and cybersecurity for investments, according to survey by GlobalData
The healthcare industry is one of the biggest in the world and it is important for healthcare systems to communicate and coordinate to facilitate efficiency. The exponential growth in technology...
-
8 January 2020
Reproductive Hormones and Protein Tests on the rise, says GlobalData
Reproductive hormones and protein tests are incredibly important for the pharmaceutical industry. They facilitate the control and regulations of many physiological processes of the human body. These processes include our...
-
19 December 2019
Big changes are set to be seen in the healthcare industry after Brexit, says GlobalData
Brexit was set to occur on the 31st October 2019, but after yet another delay, the UK isn’t set to leave the EU until the 31st January 202. Negotiations are...
-
12 December 2019
USA will continue to see most cases of heart failure, says GlobalData
Heart failure, also known as congestive cardiac failure, is a heterogeneous condition where the heart is unable to pump a sufficient volume of blood around the body to meet the...
-
12 December 2019
There are many products in the production pipeline for Type 1 Diabetes, says GlobalData
Type 1 Diabetes (T1D) is a condition that occurs due to the autoimmune destruction of pancreatic beta cells. These cells are responsible for the production of insulin, which is a...
-
9 December 2019
Huge unmet needs in glioblastoma multiforme market drives the future, says GlobalData
Glioblastoma multiforme (GBM), also known as Grade IV astrocytoma, is the most aggressive form of brain cancer and has one of the highest unmet needs in the oncology market. The...
-
9 December 2019
As prevalent cases of Multiple Sclerosis grow, new investment opportunities open up, says GlobalData
Multiple Sclerosis is an autoimmune disease affecting the central nervous system. The condition causes nerve sheath demyelination, followed by axon damage and paralysis. The symptoms of Multiple Sclerosis include muscle...
-
9 December 2019
Global medical marijuana market set to reach US$3.2bn by 2025, says GlobalData
Marijuana, or cannabis, is a plant often associated with the use of recreational drugs. Although a frequent subject of taboo and controversy, medical marijuana is a critical area of exploration...
-
28 November 2019
Biomarkers will play a key role in shaping the global CNS drug market, although cost remains a limiting factor, says GlobalData
A biomarker acts as an internal ‘fingerprint’, indicating the presence of biological conditions, pathogens, and processes. These small molecules have been long used in clinical research, and provide a unique...